How HIV and methamphetamine may harm the brain using lab-grown human 'mini-brains'

Cerebral organoid and IPSC derived microglia: Modeling of HIV and methamphetamine co-morbidity

NIH-funded research University of Nebraska Medical Center · NIH-11144958

Researchers will use lab-grown human 'mini-brains' made from stem cells to learn how HIV and methamphetamine together damage the brain in adults living with HIV.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Medical Center NIH-funded
Lab location1 site (Omaha, United States)
Project IDNIH-11144958 on NIH RePORTER

What this research studies

This project grows human induced pluripotent stem cells into 3-D cerebral organoids (mini-brains) that include immune brain cells called microglia. Investigators will control the microglia makeup and expose the organoids to HIV and methamphetamine to mimic what can happen in the brains of people with HIV who use meth. They will measure cellular injury, inflammation, and how antiretroviral drugs behave in this system to better explain HIV-associated neurocognitive problems. The model is aimed at recreating human-specific interactions difficult to study in animals.

Who could benefit from this research

Good fit: Adults living with HIV, especially those who currently use or have a history of methamphetamine use, are the group this research most directly relates to and who might provide samples or take part in related future studies.

Not a fit: People without HIV, children, or individuals with no history of methamphetamine exposure are unlikely to gain direct benefit from this basic lab-focused project.

Why it matters

Potential benefit: If successful, this work could clarify why people with HIV who use meth develop worse brain problems and help point to treatments that protect brain function.

How similar studies have performed: Prior lab studies have used iPSC-derived organoids and microglia to model brain development and some infections, but combining HIV infection and methamphetamine exposure in this human mini-brain model is relatively new.

Where this research is happening

Omaha, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency SyndromeAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency SyndromeAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.